Checkpoint Therapeutics I... (CKPT)
2.56
-0.30 (-10.49%)
At close: Mar 03, 2025, 3:59 PM
2.57
0.39%
After-hours: Mar 03, 2025, 07:08 PM EST
Checkpoint Therapeutics Balance Sheet Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 |
| Cash & Equivalents | 4.93M | 12.07M | 54.73M | 40.77M | 26.08M | 22M | 19.23M | 35.09M | 50.42M |
| Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Long-Term Assets | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Receivables | n/a | 73K | 17K | 20K | 26K | 1.53M | 331K | 821K | 65K |
| Inventory | n/a | 1.00 | n/a | 1.00 | 1.00 | n/a | 1.00 | n/a | n/a |
| Other Current Assets | 450K | 1.15M | 976K | 1.8M | 863K | 1.37M | 1.86M | 71K | 171K |
| Total Current Assets | 5.38M | 13.29M | 55.73M | 42.6M | 26.97M | 24.9M | 21.41M | 35.98M | 50.65M |
| Property-Plant & Equipment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Total Long-Term Assets | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Total Assets | 5.38M | 13.29M | 55.73M | 42.6M | 26.97M | 24.9M | 21.41M | 35.98M | 50.65M |
| Account Payables | 6.57M | 11.54M | 16.14M | 3.44M | 3.08M | 9.75M | 3.65M | 2.47M | 917K |
| Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Short-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Current Liabilities | 11.86M | 21.24M | 9.84M | 3.78M | 5.04M | 3.34M | 2.73M | 1.2M | 873K |
| Total Current Liabilities | 18.43M | 32.77M | 25.98M | 7.22M | 8.12M | 13.09M | 6.37M | 3.67M | 1.79M |
| Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2.47M |
| Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Total Long-Term Liabilities | n/a | 20.3M | n/a | n/a | n/a | n/a | n/a | n/a | 2.47M |
| Total Liabilities | 18.43M | 32.77M | 25.98M | 7.22M | 8.12M | 13.09M | 6.37M | 3.67M | 4.26M |
| Total Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2.47M |
| Common Stock | 3K | 1K | 9K | 7K | 6K | 4K | 3K | 3K | 2K |
| Retained Earnings | -314.33M | -262.49M | -199.86M | -143.19M | -120.11M | -95.4M | -59.03M | -36.35M | -13.89M |
| Comprehensive Income | n/a | 1.88M | 6.6M | 4.62M | 2.51M | 1.75M | 2.3M | 3.92M | 3.02M |
| Shareholders Equity | -13.05M | -19.48M | 29.75M | 35.38M | 18.85M | 11.81M | 15.04M | 32.3M | 46.4M |
| Total Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |